Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Natural Alternatives International Inc is a packaged foods business based in the US. Natural Alternatives International shares (NAII) are listed on the NASDAQ and all prices are listed in US Dollars. Natural Alternatives International employs 317 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$13.70|
|52-week range||$7.69 - $19.93|
|50-day moving average||$14.75|
|200-day moving average||$15.52|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$1.69|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-14)||0.29%|
|1 month (2021-09-21)||-5.19%|
|3 months (2021-07-21)||-17.52%|
|6 months (2021-04-21)||-15.54%|
|1 year (2020-10-21)||69.34%|
|2 years (2019-10-21)||47.31%|
|3 years (2018-10-19)||46.06%|
|5 years (2016-10-21)||1.48%|
Valuing Natural Alternatives International stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Natural Alternatives International's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Natural Alternatives International's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 8x. In other words, Natural Alternatives International shares trade at around 8x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Natural Alternatives International's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $19.2 million.
The EBITDA is a measure of a Natural Alternatives International's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$178.5 million|
|Operating margin TTM||8.33%|
|Gross profit TTM||$30.4 million|
|Return on assets TTM||7.73%|
|Return on equity TTM||14.22%|
|Market capitalisation||$86.9 million|
TTM: trailing 12 months
There are currently 22,395 Natural Alternatives International shares held short by investors – that's known as Natural Alternatives International's "short interest". This figure is 103.5% up from 11,006 last month.
There are a few different ways that this level of interest in shorting Natural Alternatives International shares can be evaluated.
Natural Alternatives International's "short interest ratio" (SIR) is the quantity of Natural Alternatives International shares currently shorted divided by the average quantity of Natural Alternatives International shares traded daily (recently around 46656.25). Natural Alternatives International's SIR currently stands at 0.48. In other words for every 100,000 Natural Alternatives International shares traded daily on the market, roughly 480 shares are currently held short.
However Natural Alternatives International's short interest can also be evaluated against the total number of Natural Alternatives International shares, or, against the total number of tradable Natural Alternatives International shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Natural Alternatives International's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Natural Alternatives International shares in existence, roughly 0 shares are currently held short) or 0.0048% of the tradable shares (for every 100,000 tradable Natural Alternatives International shares, roughly 5 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Natural Alternatives International.
Find out more about how you can short Natural Alternatives International stock.
We're not expecting Natural Alternatives International to pay a dividend over the next 12 months.
Natural Alternatives International's shares were split on 4 January 1990. This wouldn't directly have changed the overall worth of your Natural Alternatives International shares – just the quantity. However, indirectly, the new INF% higher share price could have impacted the market appetite for Natural Alternatives International shares which in turn could have impacted Natural Alternatives International's share price.
Over the last 12 months, Natural Alternatives International's shares have ranged in value from as little as $7.69 up to $19.93. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Natural Alternatives International's is 0.8688. This would suggest that Natural Alternatives International's shares are less volatile than average (for this exchange).
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Asia, and internationally. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. The company also provides strategic partnering services, such as customized product formulation, clinical studies, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, packaging and delivery system design, and regulatory review. In addition, it sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.